J. E. Davis sold $11M of DGX
CEO and President at QUEST DIAGNOSTICS INC. 55,093 shares at an average of $192.22, traded Nov 25, 2025, filed Nov 28, 2025.
Score components
- +25RoleCEO
- +25Trade size$10.6M at market
- +10Share of holdings soldSold 31% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001022079-25-000233, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2025 | MOption exercise Common Stock10b5-1 | +55,093 | $95.80 | $5.3M | 175,573 | Nov 28, 2025 |
| Nov 25, 2025 | SOpen-market sale Common Stock10b5-1 | -9,342 | $191.59 | $1.8M | 166,231 | Nov 28, 2025 |
| Nov 25, 2025 | SOpen-market sale Common Stock10b5-1 | -41,004 | $192.27 | $7.9M | 125,227 | Nov 28, 2025 |
| Nov 25, 2025 | SOpen-market sale Common Stock10b5-1 | -4,747 | $192.97 | $916k | 120,480 | Nov 28, 2025 |
| Nov 25, 2025 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -55,093 | $95.80 | $5.3M | 0 | Nov 28, 2025 |
Related signals
Other insiders at QUEST DIAGNOSTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $2.4M 10,000 shares | -8% | |
| 43Moderate | QUEST DIAGNOSTICS INC | Vicky B Gregg director | $240k 1,250 shares | -7% | |
| 40Moderate | QUEST DIAGNOSTICS INC | Mark E Delaney SVP & Chief Commercial Officer | $1.5M 7,946 shares | -51% | |
| 28Weak | DGXsell QUEST DIAGNOSTICS INC | Gary M Pfeiffer director | $270k 1,482 shares | -5% | |
| 0Weak | QUEST DIAGNOSTICS INC | Michael E Prevoznik SVP & General Counsel | $43k 227 shares | -1% | |
| 15Weak | QUEST DIAGNOSTICS INC | Michael E Prevoznik SVP & General Counsel | $5.3M 28,463 shares | -43% | |
| 15Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $365k 1,975 shares | -11% | |
| 8Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $829k 4,532 shares | -21% | |
| 15Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $356k 1,975 shares | -10% | |
| 18Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $969k 5,535 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.